Hologic Inc
HOLX67.160USD
+0.340+0.51%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
14.97BMarket Cap
26.88P/E TTM
More Details of Hologic Inc Company
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Company Info
Ticker SymbolHOLX
Company nameHologic Inc
IPO dateMar 01, 1990
Founded at1990
CEOMr. Stephen P. (Steve) Macmillan
Number of employees7063
Security typeOrdinary Share
Fiscal year-endMar 01
Address250 Campus Drive
CityMARLBOROUGH
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code01752
Phone15082632900
Websitehttps://www.hologic.com/
Ticker SymbolHOLX
IPO dateMar 01, 1990
Founded at1990
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen P. (Steve) Macmillan
Mr. Stephen P. (Steve) Macmillan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.22M
+7.02%
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
47.34K
+4.10%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
18.81K
+11.00%
Ms. Diana De Walt
Ms. Diana De Walt
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.02K
--
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
9.93K
-34.65%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
9.26K
+25.20%
Mr. Mark Horvath
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
Division President, Breast and Skeletal Health Solutions
7.06K
+15.71%
Mr. Brandon Schnittker
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
Division President, GYN Surgical Solutions
6.09K
-1.12%
Ms. Nanaz Mohtashami
Ms. Nanaz Mohtashami
Independent Director
Independent Director
4.18K
+80.45%
Ms. Stacey D. Stewart
Ms. Stacey D. Stewart
Independent Director
Independent Director
3.60K
+107.62%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen P. (Steve) Macmillan
Mr. Stephen P. (Steve) Macmillan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.22M
+7.02%
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
47.34K
+4.10%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
18.81K
+11.00%
Ms. Diana De Walt
Ms. Diana De Walt
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.02K
--
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
9.93K
-34.65%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
9.26K
+25.20%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Disposables
636.90M
63.35%
Service
207.90M
20.68%
Capital equipment, components and software
155.80M
15.50%
Other
4.70M
0.47%
By RegionUSD
Name
Revenue
Proportion
United States
744.90M
74.10%
Europe
146.50M
14.57%
Asia
59.70M
5.94%
Rest of World
54.20M
5.39%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Disposables
636.90M
63.35%
Service
207.90M
20.68%
Capital equipment, components and software
155.80M
15.50%
Other
4.70M
0.47%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.99%
T. Rowe Price Investment Management, Inc.
10.81%
BlackRock Institutional Trust Company, N.A.
6.04%
State Street Global Advisors (US)
4.54%
Morgan Stanley Investment Management Ltd. (UK)
3.68%
Other
62.94%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.99%
T. Rowe Price Investment Management, Inc.
10.81%
BlackRock Institutional Trust Company, N.A.
6.04%
State Street Global Advisors (US)
4.54%
Morgan Stanley Investment Management Ltd. (UK)
3.68%
Other
62.94%
Shareholder Types
Shareholders
Proportion
Investment Advisor
65.52%
Investment Advisor/Hedge Fund
28.32%
Hedge Fund
3.30%
Pension Fund
2.75%
Research Firm
2.56%
Bank and Trust
1.78%
Sovereign Wealth Fund
0.90%
Individual Investor
0.86%
Family Office
0.05%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1591
236.03M
105.92%
-8.05M
2025Q1
1635
231.71M
103.94%
-14.47M
2024Q4
1617
238.36M
106.18%
-10.05M
2024Q3
1583
240.17M
103.42%
-3.00M
2024Q2
1580
234.77M
100.61%
-6.88M
2024Q1
1595
233.34M
99.37%
-7.61M
2023Q4
1584
235.52M
98.14%
-14.13M
2023Q3
1574
242.15M
98.88%
-13.93M
2023Q2
1583
245.52M
99.77%
-12.39M
2023Q1
1582
247.98M
100.57%
-12.56M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
26.72M
11.99%
-76.11K
-0.28%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
17.69M
7.94%
-250.35K
-1.40%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
13.46M
6.04%
-188.75K
-1.38%
Mar 31, 2025
State Street Global Advisors (US)
10.11M
4.54%
-235.58K
-2.28%
Mar 31, 2025
Morgan Stanley Investment Management Ltd. (UK)
8.21M
3.68%
-232.77K
-2.76%
Mar 31, 2025
Victory Capital Management Inc.
6.61M
2.97%
+1.69M
+34.41%
Mar 31, 2025
Geode Capital Management, L.L.C.
5.73M
2.57%
-948.00
-0.02%
Mar 31, 2025
Mitsubishi UFJ Asset Management Co., Ltd.
4.47M
2.01%
+69.88K
+1.59%
Mar 31, 2025
Invesco Capital Management LLC
4.37M
1.96%
+716.65K
+19.63%
Mar 31, 2025
Columbia Threadneedle Investments (US)
3.40M
1.53%
+19.27K
+0.57%
Mar 31, 2025
View more
Related ETFs
Updated: 7 hours ago
Updated: 7 hours ago
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
4%
John Hancock Fundamental All Cap Core ETF
3.42%
LeaderShares AlphaFactor Tactical Focused ETF
3.32%
First Trust Indxx Medical Devices ETF
2.07%
Formidable ETF
1.96%
First Trust Health Care Alphadex Fund
1.87%
SPDR S&P Health Care Equipment ETF
1.84%
Brandes US Small-Mid Cap Value ETF
1.79%
Invesco S&P 500 Equal Weight Health Care ETF
1.67%
iShares U.S. Medical Devices ETF
1.65%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion4%
John Hancock Fundamental All Cap Core ETF
Proportion3.42%
LeaderShares AlphaFactor Tactical Focused ETF
Proportion3.32%
First Trust Indxx Medical Devices ETF
Proportion2.07%
Formidable ETF
Proportion1.96%
First Trust Health Care Alphadex Fund
Proportion1.87%
SPDR S&P Health Care Equipment ETF
Proportion1.84%
Brandes US Small-Mid Cap Value ETF
Proportion1.79%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.67%
iShares U.S. Medical Devices ETF
Proportion1.65%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
